De Célix, CR, Granja, A, Iborra, M, Alonso, FJG, Vela, M, de Castro, L, García-Sola, C, Barrero, S, Trastoy, PV, Andrés, PR, Riestra, S, Diaz, AP, Santos, DC, Camps, B, Gisbert, J, García, MJ, Palomares, MTDL, Lozano, OM, de la Cruz, DR, López, E, Pascual, CM, Izquierdo, S, Flores, EI, Iglesias, RF, Argüelles-Arias, F, Martin, D, Ramírez, MAR, Villaamil, PV, Martinez, AMT, Ramos, CR, Velázquez, LM, Ciria, MM, Brunet, E, Zabana, Y, Villarroya, RP, Altadill, A, Moral, ED, Mateu, PN, Acosta, MBD, San Jose, FB. Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.069. PMID:. IF:8.700(Q1/1D).

Calvo, M, Fernández-Felix, BM, Jiménez, IO, Guardia, JL, Menéndez, SR, Gismero, FM, Parga, MLD, Trastoy, PV, Vela, M, Carrasco, NM, Gargallo-Puyuelo, C, Ramos, CR, Arranz, MDM, Rivas, C, Capón, JG, Garcia, LA, Casbas, AG, San Jose, FB, Gonzalez, S, Lucia, M, Elorza, A, Sepulcre, MFG, Fernández-Salazar, L, Mínguez, A, Quiñones, M, Taxonera, C, Barreiro-de Acosta, M, Diaz, AP, Flores, EI, Cano, MP, Sese, E, Casals, DB, Bas-Cutrina, F, Glaría, EB, Moreno, AZG, Poceiro, JC, Lopez, LR, Moral, ED, Chaparro, M, Gisbert, J. Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.897. PMID:. IF:8.700(Q1/1D).

de Célix, CR, Ricart, E, Martín-Arranz, MD, de Francisco, R, García-Alonso, FJ, Mesonero, F, Gomollón, F, de Castro, L, Ramos, L, García-López, S, Arias, L, Mañosa, M, Iglesias, E, Calvet, X, Bolufer, CS, Casanova, MJ, Pérez-Calle, JL, Giordano, A, Sierra-Ausín, M, Vera, I, Navarro-Llavat, M, Lorente, R, Piqueras, M, Rivero, M, Guardiola, J, Esteve, M, Coronel, AF, Rodríguez-Lago, I, Ponferrada-Díaz, A, Ber, Y, Tardillo, C, Márquez, L, Carpio, D, Taxonera, C, Bermejo, F, Busquets, D, Camps, B, Gutiérrez, A, García-Sepulcre, MF, Barreiro-de Acosta, M, Marín-Jiménez, I, Huguet, JM, Fernández-Salazar, LI, Jaó, J, Rodríguez-Gutiérrez, C, Martinez-Flores, C, Bujanda, L, Lucendo, AJ, Sesé, E, Andrés, PR, Ginard, D, Vega, P, Riera, J, Pajares, R, Van Domselaar, M, Almela, P, Pérez, TM, Muñoz-Villafranca, C, Varela, P, Argüelles-Arias, F, Nos, P, Alcaín, G, Hernández, L, Fernández, H, Muñoz, F, Gilabert, P, Navas-López, VM, de la Piscina, PR, Sánchez, LB, Gil, JL, Valldosera, G, Muñoz, RA, Frago, S, Domènech, E, Chaparro, M, Gisbert, JP. Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; 63(1)DOI:10.1111/apt.70312. PMID:40778752. IF:6.700(Q1/1D).

Marquès-Camí, M, Vergés, L, Gonzalez, AE, Huguet, JM, Mateos, AMC, Caravaca, C, Molina, IGD, Suárez, C, Carballo-Folgoso, L, Vivo, MG, Cuadro, CP, Vicente, GT, Martin, MDCL, Ramos, CR, Jimenez, BV, Clotet, AF, Sandoval, CT, Torres, VM, Intriago, AC, Brunet, E, Martín, J, Marin, CAT, Medina, LT, Lozano, OM, Mínguez, A, Velázquez, LM, Sard, MC, Zabana, Y. Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.468. PMID:. IF:8.700(Q1/1D).